Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

No phase data available

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT07374796Not Yet Recruiting

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Breast Cancer

Role: collaborator

NCT07528430Not Yet Recruiting

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer

Role: collaborator

NCT07008664Recruiting

Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Lung Cancer

Role: collaborator

All 3 trials loaded